Synthesis of sericin-based conjugates by click chemistry: enhancement of sunitinib bioavailability and cell membrane permeation

References

• Akash MSH, Rehman K, Parveen A, et al. (2016). Antibody-drug conjugates as drug carrier systems for bioactive agents. Int J Polym Mater Polym Biomater 65:1–10
   Web of Science ®Google Scholar
• Alley SC, Okeley NM, Senter PD. (2010). Antibody-drug conjugates: targeted drug delivery for cancer. Curr Opin Chem Biol 14:529–37
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, et al. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–20
   PubMed Web of Science ®Google Scholar
• Ampawong S, Aramwit P. (2016). Tolerogenic responses of CD206+, CD83+, FOXP3+, and CTLA-4 to sericin/polyvinyl alcohol/glycerin scaffolds relevant to IL-33 and HSP60 activity. Histol Histopathol 31:1011–27
   PubMed Web of Science ®Google Scholar
• Aramwit P, Siritientong T, Srichana T. (2011). Potential applications of silk sericin, a natural protein from textile industry by-products. Waste Manag Res 30:217–24
   PubMed Web of Science ®Google Scholar
• Bouayed J, Hoffmann L, Bohn T. (2011). Total phenolics, flavonoids, anthocyanins and antioxidant activity following simulated gastro-intestinal digestion and dialysis of apple varieties: bioaccessibility and potential uptake. Food Chem 128:14–21
   PubMed Web of Science ®Google Scholar
• Coburn JM, Kaplan DL. (2015). Engineering biomaterial-drug conjugates for local and sustained chemotherapeutic delivery. Bioconjug Chem 26:1212–23
   PubMed Web of Science ®Google Scholar
• Deng L, Zhang H, Yang M, et al. (2014). Improving properties of superabsorbent composite induced by using alkaline protease hydrolyzed‐sericin (APh‐sericin). Polymer Compos 35:509–15
   Web of Science ®Google Scholar
• Di Gion P, Kanefendt F, Lindauer A, et al. (2011). Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles. Clin Pharmacokinet 50:551–603
   PubMed Web of Science ®Google Scholar
• Etrych T, Šubr V, Strohalm J, et al. (2012). HPMA copolymer-doxorubicin conjugates: the effects of molecular weight and architecture on biodistribution and in vivo activity. J Control Release 164:346–54
   PubMed Web of Science ®Google Scholar
• Fattahi A, Asgarshamsi M, Hasanzadeh F, et al. (2015). Methotrexate-grafted-oligochitosan micelles as drug carriers: synthesis and biological evaluations. J Mater Sci Mater Med 26:1–10
   Web of Science ®Google Scholar
• Grande F, Parisi OI, Mordocco RA, et al. (2016). Quercetin derivatives as novel antihypertensive agents: synthesis and physiological characterization. Eur J Pharm Sci 82:161–70
   PubMed Web of Science ®Google Scholar
• Herbrink M, Nuijen B, Schellens JH, et al. (2015). Variability in bioavailability of small molecular tyrosine kinase inhibitors. Cancer Treat Rev 41:412–22
   PubMed Web of Science ®Google Scholar
• Iacopetta D, Rosano C, Puoci F, et al. (2017). Multifaceted properties of 1,4-dimethylcarbazoles: focus on trimethoxybenzamide and trimethoxyphenylurea derivatives as novel human topoisomerase II inhibitors. Eur J Pharm Sci 96:263–72
   PubMed Web of Science ®Google Scholar
• Iemma F, Puoci F, Curcio M, et al. (2010). Ferulic acid as a comonomer in the synthesis of a novel polymeric chain with biological properties. J Appl Polym Sci 115:784–9
   Web of Science ®Google Scholar
• Izzedine H, Buhaescu I, Rixe O, et al. (2007). Sunitinib malate. Cancer Chemother Pharmacol 60:357–64
   PubMed Web of Science ®Google Scholar
• Jabbour E, Kantarjian H, Cortes J. (2015). Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm. Clin Lymphoma Myeloma Leuk 15:323–34
   PubMed Web of Science ®Google Scholar
• Kassem MG, Motiur Rahman AFM, Korashy HM. 2012. Chapter 9 – Sunitinib malate. In: Harry GB, ed. Profiles of drug substances, excipients and related methodology. Cambridge, MA: Academic Press, 363–88
   Google Scholar
• Kok R, Grijpstra F, Nederhoed K, et al. (1999). Renal drug delivery with low-molecular-weight proteins: the effect of charge modifications on the body distribution of drug-lysozyme conjugates. Drug Deliv 6:1–8
   Web of Science ®Google Scholar
• Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–5
   PubMed Web of Science ®Google Scholar
• Lamboni L, Gauthier M, Yang G, et al. (2015). Silk sericin: a versatile material for tissue engineering and drug delivery. Biotechnol Adv 33:1855–67
   PubMed Web of Science ®Google Scholar
• Liu B, Song Y-W, Jin L, et al. (2015). Silk structure and degradation. Colloids Surf B Biointerfaces 131:122–8
   PubMed Web of Science ®Google Scholar
• Madeo M, Carrisi C, Iacopetta D, et al. (2009). Abundant expression and purification of biologically active mitochondrial citrate carrier in baculovirus-infected insect cells. J Bioenerg Biomembr 41:289–97
   PubMed Web of Science ®Google Scholar
• Moscho A, Orwar O, Chiu DT, et al. (1996). Rapid preparation of giant unilamellar vesicles. Proc Natl Acad Sci USA 93:11443–7
   PubMed Web of Science ®Google Scholar
• Napavichayanun S, Amornsudthiwat P, Pienpinijtham P, et al. (2015). Interaction and effectiveness of antimicrobials along with healing-promoting agents in a novel biocellulose wound dressing. Mater Sci Eng C 55:95–104
   PubMed Web of Science ®Google Scholar
• Padamwar M, Pawar A. (2004). Silk sericin and its applications: a review. J Sci Ind Res 63:323–9
   Web of Science ®Google Scholar
• Pang X, Du H-L, Zhang H-Q, et al. (2013). Polymer-drug conjugates: present state of play and future perspectives. Drug Discov Today 18:1316–22
   PubMed Web of Science ®Google Scholar
• Papaetis GS, Syrigos KN. (2009). Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies. BioDrugs 23:377–89
   PubMed Web of Science ®Google Scholar
• Parisi OI, Fiorillo M, Scrivano L, et al. (2015a). Sericin/poly (ethylcyanoacrylate) nanospheres by interfacial polymerization for enhanced bioefficacy of fenofibrate: in vitro and in vivo studies. Biomacromolecules 16:3126–33
   PubMed Web of Science ®Google Scholar
• Parisi OI, Morelli C, Scrivano L, et al. (2015b). Controlled release of sunitinib in targeted cancer therapy: smart magnetically responsive hydrogels as restricted access materials. RSC Adv 5:65308–15
   Web of Science ®Google Scholar
• Puoci F, Morelli C, Cirillo G, et al. (2012). Anticancer activity of a quercetin-based polymer towards HeLa cancer cells. Anticancer Res 32:2843–7
   PubMed Web of Science ®Google Scholar
• Roskoski R. (2007). Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun 356:323–8
   PubMed Web of Science ®Google Scholar
• Saturnino C, Sinicropi MS, Parisi OI, et al. (2014). Acetylated hyaluronic acid: enhanced bioavailability and biological studies. BioMed Res Int 2014:1–7
   Web of Science ®Google Scholar
• Savitzky A, Golay MJ. (1964). Smoothing and differentiation of data by simplified least squares procedures. Anal Chem 36:1627–39
   Web of Science ®Google Scholar
• Siritientong T, Bonani W, Motta A, et al. (2016). The effects of Bombyx mori silk strain and extraction time on the molecular and biological characteristics of sericin. Biosci Biotechnol Biochem 80:241–9
   PubMed Web of Science ®Google Scholar
• Song Y, Jin Y, Sun J, et al. (2006). Graft copolymerization of methyl acrylate onto silk sericin initiated by tert‐butyl hydroperoxide. Polym Int 55:1350–4
   Web of Science ®Google Scholar
• Takegami S, Kitamura K, Ohsugi M, et al. (2015). Partitioning of organophosphorus pesticides into phosphatidylcholine small unilamellar vesicles studied by second-derivative spectrophotometry. Spectrochim Acta A Mol Biomol Spectros 145:198–202
   PubMed Web of Science ®Google Scholar
• Vicent MJ. (2007). Polymer-drug conjugates as modulators of cellular apoptosis. AAPS J 9:E200–07
   PubMed Web of Science ®Google Scholar
• Vittorio O, Cirillo G, Iemma F, et al. (2012). Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma. Pharm Res 29:2601–14
   PubMed Web of Science ®Google Scholar
• Walde P, Cosentino K, Engel H, et al. (2010). Giant vesicles: preparations and applications. ChemBioChem 11:848–65
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang Z, Yao H, et al. (2014). Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials. Drug Des Dev Ther 8:2061
   PubMed Web of Science ®Google Scholar
• Zhang Y-Q, Ma Y, Xia Y-Y, et al. (2006a). Silk sericin–insulin bioconjugates: Synthesis, characterization and biological activity. J Control Release 115:307–15
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Tao ML, Shen WD, et al. (2006b). Synthesis of silk sericin peptides–L‐asparaginase bioconjugates and their characterization. J Chem Technol Biotechnol 81:136–45
   Web of Science ®Google Scholar
• Zhao L, Liu C, Sun Y, et al. (2012). A rapid and simplified method for protein silver staining in polyacrylamide gels. Electrophoresis 33:2143–4
   PubMed Web of Science ®Google Scholar